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Negative-ion matrix-assisted laser desorption/ionization mass spectra of sialylated glycocon-
jugates were acquired employing 2,5-dihydroxybenzoic acid (DHB) in conjunction with
spermine as a co-matrix. The addition of spermine to DHB permitted an improved crystal
formation as well as a higher analyte solubility. Moreover, DHB/spermine appears to
minimize alkali adduct formation, thus allowing the sample analysis without desalting. The
combined matrix permitted the analysis of complex sialylated and sialylated/fucosylated
structures down to the femtomole range. The ability to use such a matrix also facilitates
determination of the sialic acid linkages (in combination with a specific enzyme cleavage). The
matrix also appears suitable for studies on gangliosides. (J Am Soc Mass Spectrom 1998, 9,
1293–1302) © 1998 American Society for Mass Spectrometry
An increasing need to understand the numerousfunctions of glycoconjugates in biological sys-tems has stimulated intensive search for new
strategies toward structural elucidation of carbohy-
drates. During the most recent period, mass-spectro-
metric (MS) techniques have been increasingly applied
to characterize glycan moieties in various biologically
important molecules. Mass spectrometry offers distinct
advantages over the more conventional approaches
because of its inherent sensitivity and, potentially, its
capability to solve complex structures through tandem
(MS/MS) techniques.
The power of MS/MS techniques in structural eluci-
dation of complex oligosaccharides has particularly
been demonstrated through the use of matrix-assisted
laser desorption/ionization (MALDI) mass spectrome-
try. The appealing features of this approach were
shown through an in-source decay with a magnetic
sector instrument [1], postsource decay on a reflectron
time-of-flight (TOF) instrument [1–3] and collision-in-
duced dissociation (CID) on either a magnetic sector
instrument fitted with an orthogonal TOF analyzer [1],
or an external-source Fourier-transform mass spectrom-
eter adopting a MALDI source [4]. These various ap-
proaches provide the basic means to fragment the
oligosaccharide analytes, permitting a determination of
sequence, branching, and the linkage forms in a studied
molecule.
However, the MALDI/MS of oligosaccharides is not
without problems. The presence of sialylated structures
generally complicates the acquisition of analytically
desirable MALDI spectra. The negatively charged sialic
acid groups that often reside at the oligosaccharides’
ends are easily lost during the highly energetic MALDI
process [5, 6]. Also, a MALDI analysis of sialylated
oligosaccharides in the positive-ion mode yields a mix-
ture of cation adducts, thus reducing signal intensity.
These problems generally account for the poorer detec-
tion limits (picomole range) of acidic oligosaccharides
unless a unique matrix is used [7]. Moreover, the
problems become more pronounced as the number of
acidic groups present in an oligosaccharide structure
increases.
In order to avoid the problems associated with the
MALDI instability of acidic oligosaccharides, it is feasi-
ble to treat the sample with a suitable enzyme, such as
neuraminidase, which removes the sialic acid residues.
Regrettably, this procedure often destroys much useful
biochemical information, as the sialic acids have often
been implicated in biochemical recognition [8]. Addi-
tional approaches leading to improvements in detect-
ability of acidic oligosaccharides in MALDI/MS include
the use of matrices that have been proven effective in
the analysis of oligonucleotides [7], an addition of
cation-exchange resin beads to the sample solution
(either directly on the probe, or prior to crystallization)
[9], an esterification of sialylated structures prior to a
MALDI/MS analysis [10], use of basic peptides and
proteins as a co-matrix [11], or the utilization of mem-
brane microdialysis [12]. Most, if not all, of these
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procedures may result in sample dilution or adsorptive
losses.
Yet another approach demonstrated as effective in
the MALDI/MS analysis of oligonucleotides involves
the use of organic bases as co-matrices [13–16]. How-
ever, only some organic bases appear appropriate for
the elimination of nonvolatile cation (e.g., sodium)
adducts. This is because the fact that certain bases not
only reduce cation adduction, but also decrease ion
abundance through formation of a crystal.
We report here the use of spermine as a highly
effective co-matrix to dihydroxy benzoic acid (DHB), a
widely used matrix in carbohydrate analysis. The pro-
cedure reported here permits the analysis of acidic
glycoconjugates as negative ions, at very low detection
limits, and there is no need for cleanup or desalting
procedures. The effectiveness of this sample prepara-
tion procedure has been tested here with standard
acidic oligosaccharides, gangliosides, as well as the
sialylated N-linked glycans released enzymatically
from bovine fetuin, human a1-acid glycoprotein (AGP)
and human tranferrin.
Experimental
Materials
The standard glycoproteins (human AGP, transferrin,
and bovine fetuin), N-acetylneuraminyl-lactose and N-
acetylneuraminyl-lacto-N-neo-tetrose (both originated
from human milk), 2,5-dihydroxybenzoic acid, ganglio-
sides type IV from bovine brain, maltose ladder and
spermine (N,N9-bis[3-aminopropyl]-1,4-butanediamine
tetrahydrochloride) were obtained from Sigma Chemi-
cal (St. Louis, MO). The recombinant enzyme N-glyco-
sidase F (PNGase F) from E. coli [EC 3.2.2.18] and
neuraminidase from Newcastle disease virus [EC
3.2.118] were purchased from Boehringer Mannheim
(Indianapolis, IN). The labeling reagent, 8-aminopy-
rene-2,3,4-trisulfonic acid (APTS) was received from
Molecular Probes (Eugene, OR). The standard complex
oligosaccharides (fucosylated, disialylated biantennary
and trisialylated triantennary) were purchased from
Oxford GlycoSystems (Wakefield, MA). All remaining
chemicals were from Aldrich (Milwaukee, WI).
Methods
Enzymatic cleavages. The N-linked oligosaccharides
were enzymatically released from their respective gly-
coproteins. Briefly, the glycoproteins to be digested
were reconstituted in 0.025 M sodium phosphate buffer
(pH 7.5), followed by the addition of PNGase F (5
mUnit/0.1 mg glycoprotein). The samples were subse-
quently incubated for 18 h at 37°C.
The enzymatically released oligosaccharides were
recovered by applying the digestion mixtures to C18
Sep-Pak cartridges (Waters Corporation, Milford, MA)
which had been preconditioned with methanol, aceto-
nitrile, and aqueous methanol (1:19 v/v). The oligosac-
charides were eluted with 3 mL of 10% aqueous meth-
anol solution, lyophilized, or dried under a stream of
nitrogen, and reconstituted in water to the initial gly-
coprotein concentration of 2 mg/mL.
Sialylated oligosaccharides were treated with neur-
aminidase from Newcastle disease virus by reconstitut-
ing 2.0 mL the oligosaccharide stock solution in 10 mM
sodium acetate buffer (pH 5.5), followed by the addi-
tion of neuraminidase (approximately 20 mU per nmol
of a substrate) and incubation for 12 h. Prior to their
MALDI analysis, the samples were dried and reconsti-
tuted in 2.0 mL water.
Labeling of the maltose ladder. Maltooligosaccharides
were labeled with APTS through reductive amination
[17]. The maltose ladder was dissolved in 2 mL of 150
mM APTS (prepared in a 3:17 ratio of acetic acid:
DMSO) and 2 mL 1.0 M sodium cyanoborohydride in
water. The reaction mixture was vortexed prior to
incubation in a heating block at 90°C for 2 h. Prior to its
mass spectrometry analysis, the sample was drop dia-
lyzed against deionized water for 2 h using a 1000
MWCO dialysis membrane. This APTS-labeled maltose
ladder was used exclusively for MALDI calibration.
Sample and matrix preparation. The MALDI matrix was
prepared by dissolving DHB crystals in 300 mM aque-
ous solution of spermine to obtain a saturated DHB
solution. The matrix solution was then desalted by
adding a few cation-exchange resin beads (NH4
1 ionic
form) to minimize the presence of sodium ions in the
matrix. The samples were prepared by spotting 0.5 mL
sample aliquots on a polished stainless-steel sample
plate, followed by addition of 1.5 mL of the matrix
solution. The spots were allowed to dry at room tem-
perature.
Instrumentation
All mass spectra were acquired on a Voyager-DE RP
Biospectrometry Workstation (PerSeptive Biosystems,
Framingham, MA) equipped with a pulsed nitrogen
laser (337 nm). The instrument can operate in both the
reflector and linear modes and has the delayed ion-
extraction capability. The linear mode was solely used
in the negative ion mode. The MALDI spectra were
acquired at 18 kV accelerating voltage, with delay
extraction. The delay time was set to 150 ns, in addition
to the instrumental delay caused by the detection elec-
tronics. A two-point external calibration was performed
on the instrument prior to an analysis, utilizing the
negatively charged APTS-labeled maltose ladder,
achieving mass accuracy of 0.1% or better. All acquired
spectra were smoothed by applying the 19-point Savitz-
ky–Golay smoothing [18]. The MALDI instrument used
in this report utilizes a multichannel plate detector and,
in order to preclude the low mass ions from saturating
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the detector, the low-mass ion gate was set at 1000 Da in
the case of N-linked oligosaccharide samples.
Results and Discussion
The MALDI matrices are supposed to absorb the laser
light energy and facilitate desorption and ionization of
a sample. The mixture of a sample with matrix is
assumed to be vaporized from the surface of the target
plate upon irradiation with the laser pulses [19]. More-
over, the irradiation may also catalyze a chemical
conversion, leading to either protonated or alkaliated
molecules in the positive ion mode, or deprotonated
molecules in the negative ion mode. Although the
details of ionization process are somewhat nebulous, it
would appear that photochemical products from the
matrix are responsible for the ionization [19]. It is
further believed that a close contact between the matrix
and the sample is essential for the formation of sample
ions. A cocrystallization of the matrix and sample may
aid accomplishing this.
In the case of DHB matrix, crystallization tends to
occur at the periphery of the target spot in the form of
long needles pointing toward the center of the target
(Figure 1a). Such crystallization is believed to be re-
sponsible for a weak signal observed under such con-
ditions. Some improvements are expected through re-
crystallization of the spotted material with ethanol [20].
Karas et al. [21] also succeeded in incorporating certain
additives into the DHB matrix and achieved crystalli-
zation in more even layers which were observed to
improve MALDI analysis of neutral oligosaccharides.
To facilitate the use of DHB as a matrix for the
analysis of acidic oligosaccharides, we have experi-
mented with the application of various organic bases as
the additives which could minimize, or even eliminate,
cation adduction. Encouraged by an earlier success [22]
with correlation between microcrystallinity of neutral
arabinosazone and its desirable MALDI behavior vis-
a`-vis neutral oligosaccharides, we sought a uniform
crystal appearance while experimenting with different
organic base additives. Some initial experiments with
imidazole were only marginally successful, presumably
because of the fact that only a translucent spot was
obtained after drying the mixture of sample and matrix
under any imidazole concentration (Figure 1b). Sperm-
ine proved to be a more useful additive, permitting a
formation of well defined crystals (Figure 1c). At its
optimum concentration of 300 mM, spermine in a
co-matrix with DHB facilitated a highly desirable
MALDI behavior for various acidic oligosaccharides, as
demonstrated on several examples below.
In order to determine the additive effect of spermine
on spectroscopic properties of DHB, UV absorption
spectra of saturated DHB solutions were compared in
the presence and absence of 300 mM spermine (Figure
2). Apparently, no major spectral shifts were observed
following the inclusion of spermine, although the solu-
tion absorbance increased. This is presumably because
of the higher solubility of DHB in the spermine aqueous
solution.
It has been observed in this laboratory that sensitiv-
Figure 1. The effects of co-matrix on crystallization: (a) a spot made by mixing 0.5 mL sample with
1 mL saturated aqueous DHB solution; (b) a spot made by mixing 0.5 mL sample with 1 mL saturated
aqueous DHB solution in 300 mM imidazole; and (c) a spot made by mixing 0.5 mL sample with 1 mL
saturated DHB solution in 300 mM spermine.
Figure 2. UV spectra of saturated DHB aqueous solution (1), 300
mM spermine prepared in saturated DHB aqueous solution (2),
and saturated DHB solution prepared in 300 mM spermine
aqueous solution (3).
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ity of MALDI/MS in the analysis of acidic oligosaccha-
rides using DHB as a matrix is at least an order of
magnitude less than for the neutral oligosaccharides. To
assess the improvement in sensitivity after the inclusion
of spermine as a co-matrix, four standard glycans were
utilized: N-acetylneuramine-lactose (NeuAc-Lac) and
N-acetylneuramine-lacto-N-neo-tetrose (NeuAc-LacN),
both isolated from human milk; a complex-type disia-
lylated biantennary, N-linked oligosaccharide with a
core fucose (A2F); and a complex-type trisialylated,
galactosylated triantennary N-linked oligosaccharide
(A3). The human milk glycans gave clearly the expected
negative-ion signals (m/z 631.02 for NeuAca2-3/6
Galb1-4Glc, and m/z 997.77 for NeuAca2-6Galb1-
4GlcNAcb1-3Galb1-4Glc) at 50 fmol level. Equally suc-
cessful were the runs with A2F and A3 oligosaccha-
rides, with their mass spectra illustrated in Figure 3a, b.
In the case of A2F, a major signal is observed at m/z
2369, corresponding to [M 2 H]2. Four additional
signals were detected at m/z 2078, 2392, 2423, and
2469. The value at 2078 corresponds to the parent
structure minus one sialic acid group. However, the
occurrence of this signal is unlikely to be because of a
facile fragmentation of A2F, but rather a contamination
Figure 3. Negative-ion spectra of complex oligosaccharides: 50 fmol A2F (a) and 50 fmol A3 (b).
Symbols: open circle 5 mannose, filled square 5 N-acetylglucosamine, open square 5 galactose, filled
circle 5 fucose, and open triangle 5 N-acetylneuraminic acid.
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in the standard: a chromatogram obtained through the
pulsed-amperometric detection (provided by the sup-
plier) showed clearly a peak corresponding to a mono-
sialylated structure. Contamination is also believed to
be responsible for m/z 2423 and 2469 (as consistent
with the manufacturer’s chromatographic data),
whereas m/z 2392 (Figure 3a) corresponds to
[M1Na 2 2H]2.
In the spectrum of A3 (Figure 3b), two prominent
peaks appear at m/z 2879 and 2921, corresponding to
[M 2 H]2 ion and an O-acetylated A3 ([M1CH2CO 2
H]2), respectively. The very weak signal at m/z 2588
seems to correspond to a loss of one sialic acid residue.
Once again, the manufacturer’s chromatogram impli-
cated these as impurities. It should be noted that the
standard oligosaccharides were prepared in pure aque-
ous solutions, so that the major signals observed for
A2F and A3 were the deprotonated ions. However,
when the standards were prepared in solution at a
moderate buffer concentration (e.g., in 50 mM phos-
phate buffer), sensitivity was not drastically reduced,
with the major ions appearing as sodium adducts (data
not shown).
Although the above data on standard oligosaccha-
rides were essential to establish the detection attributes
of negative-ion MALDI/MS using spermine as a co-
Figure 4. Negative-ion spectra of the N-linked oligosaccharides derived from the equivalent to 1 mg
human AGP before (a) and after (b) drop dialysis. Symbols as in Figure 3.
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matrix, application to the actual glycoprotein analysis
has further been desirable. As demonstrated below, the
DHB/spermine matrix (unlike a previously used THAP
matrix [7]) is effective in the analysis of glycoprotein
hydrolyzates without an essential need for desalting
procedure. Understandably, additional desalting (drop
dialysis [12]) improves the detection performance (Fig-
ure 4a vs. b), as shown with the example of human AGP
N-glycans after their enzymatic release. Although a
minor degree of fragmentation is observed in both cases
(Figure 4a, b), the major signals are easily implicating
the structures known to exist [23] in human AGP. The
spectrum illustrated in Figure 4a, b does not show
signals for some N-glycans structures that are known to
exist in AGP (i.e., tetraantennary and fucosylated tet-
raantennary) [23]; however, the lack of signals for these
structures is not because of the inability of the matrix to
ionize larger structures, but rather to the fact that these
structures were not cleaved from the glycoprotein. With
the procedure used here, the two disulfide bonds exist-
ing in AGP were not cleaved prior to deglycosylation,
causing incomplete deglycosylation. This was sup-
ported by a complete agreement between the spectral
profiles observed with the sialylated oligosaccharides
and their corresponding desialylated structures. When
no desalting is performed (Figure 4a), the major mass-
to-charge ratio values correspond to the sodium ad-
ducts: 2245, 2923, and 3069, corresponding to [M1Na 2
2H]2, [M12Na 2 3H]2, and [M12Na 2 3H]2, respec-
tively. (Note that the number of sodium adducts is
equivalent to the number of acidic groups minus one.)
Although monosodium adduction was observed in the
case of trisialylated structures (Figure 4a), the signal
intensities were weaker than for the disodiated species.
The obtained sensitivity is genuinely high: the signals
observed in Figure 4 reflect the N-glycans released from
just 1.0 mg of human AGP, as determined from 2
mg/mL concentration of the N-glycan stock solution.
N-Glycans released from bovine fetuin, one of the most
documented glycoproteins, are shown in Figure 5. The
major signals observed at m/z 1933, 2223, 2298, 2589,
2879, and 3171 correspond to [M 2 H]2 ions of the
monosialylated biantennary, disialylated biantennary,
trisialylated triantennary, and tetrasialylated trianten-
nary structures, respectively. These are the N-glycan
structures known to exist [24] in fetuin, whereas the
intensities of their respective signals reflect well the
percentages in which they are commonly encountered.
No extensive fragmentation of these parent structures
was observed. Once again, we observed that desalting
enhanced peak intensities with bovine fetuin as well
(data not shown).
Because of its capability to analyze intact sialylated
glycans, the DHB/spermine matrix in conjunction with
the utility of specific neuraminidases and the subse-
quent MALDI/MS analysis can also be effectively used
Figure 5. Negative-ion spectra of the N-linked oligosaccharides derived from the equivalent to 1 mg
bovine fetuin. Symbols as in Figure 3.
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to probe the sialic acid linkages existing in acidic
structures. As an example, the negative-ion spectra of
the acidic oligosaccharides isolated from bovine fetuin
and human AGP are shown (Figure 6a, b) after the
glycans were treated with neuraminidase from New-
castle disease virus. This enzyme is known to hydrolyze
specifically terminal a(2–3)-bound sialic acids of either
N- or O-linked glycans. The enzymatic treatment of the
N-glycans from bovine fetuin caused disappearance of
some signals and enhancement of native glycans (com-
pare Figures 5 and 6a). The signals recorded after
treatment with this neuraminidase corresponded to a
disialylated triantennary (m/z 2609), monosialylated
triantennary (m/z 2296), and monosialylated bianten-
nary (m/z 1931) structures. A very weak signal corre-
sponding to a disialylated biantennary structure (m/z
2244) was also observed. It can thus be concluded that
none of the tri- or tetrasialylated structures have the
sialic acid groups linked solely via a(2–6) linkage (no
signals at m/z 2879 or 3171 were observed). In com-
parison, the positive-ion spectra (data not shown) of
N-glycans from the same origin (after treatment with
the same neuraminidase) exhibited signals at mass-to-
charge ratio values corresponding to the biantennary
and triantennary structures, suggesting the sialic acid
attachments of the a(2–3) type. Although this method
Figure 6. Negative-ion spectra of the N-linked oligosaccharides from bovine fetuin (a) and human
AGP (b) treated with neuraminidase from Newcastle disease virus. Symbols as in Figure 3, and filled
triangle 5 N-acetylneuraminic acid a(2–6).
1299J Am Soc Mass Spectrom 1998, 9, 1293–1302 MALDI/TOF OF GLYCOCONJUGATES AS NEGATIVE IONS
allowed determination of the sialic acid linkages exist-
ing in sialylated oligosaccharides, it cannot provide the
information on a specific antenna on which such link-
ages exist.
The negative-ion MALDI spectrum of the N-glycans
from human AGP differed, after treatment with neur-
aminidase from Newcastle disease virus, from the orig-
inal (untreated) sample (compare Figures 4 and 6b). The
mass-to-charge ratio values determined from the nega-
tive-ion spectrum corresponded to a monosialylated
biantennary (m/z 1930), disialylated biantennary (m/z
2244), monosialylated triantennary (m/z 2297), mono-
sialylated/fucosylated triantennary (m/z 2443), disia-
lylated triantennary (m/z 2611), and disialylated/
fucosylated triantennary (m/z 2757) structures. These
negative-ion spectra suggest the presence of structures
featuring a mixture of sialic acid groups that are both
a(2–3) and a(2–6) linked. In addition, a positive-ion
MALDI spectrum of AGP N-glycans treated with neur-
aminidase (results not shown) exhibited signals corre-
sponding to biantennary, triantennary, and fucosylated
triantennary structures, thus suggesting the presence of
structures that possesses sialic acid residues solely as
a(2–3) linked. Thus, combining the data from both the
negative- and positive-ion spectra with the enzymatic
selectivity should reveal the true heterogeneity of sialic-
acid linkages associated with N-glycans.
Because the combined DHB/spermine matrix
proved effective for the acquisition of negative-ion
spectra with acidic oligosaccharides, an extension to
gangliosides (which also feature sialic residues) ap-
peared natural. Gangliosides are glycosphingolipids
consisting of a hydrophilic sialooligosaccharide chain
and a hydrophobic ceramide moiety which contains a
sphingosine and a fatty acid. A type IV ganglioside
mixture essentially contains GM1, GD1a, GD1b, and GT1b
(see Diagram 1).
In agreement with these structures, a negative-ion
spectrum acquired for these gangliosides (Figure 7a)
features three major regions because of various mixture
constituents. The intensities of the signals observed
reflect the natural concentration at which each of these
gangliosides exist in a type IV mixture [25]. We note
that each ganglioside type is responsible for two signals
that differs by 28 m/z and correspond to sphingenine
(d18:1) and icosasphingenine (d20:1) for each structure.
The ceramide nomenclature depicted between the
brackets indicate the number of hydroxy groups (e.g.,
0d9 for dihydroxy), the number of carbon atoms, and the
degree of saturation, respectively. The additional mul-
tiple signals observed in Figure 7a are not because of a
multiple adduct formation, but rather because of the
lactones formed between the sialic acid groups and the
preceding galactose residues [25]. Fortunately, these
lactones can be eliminated by treatment with ammo-
nium hydroxide, as depicted in Figure 7b. As a result of
this treatment, the negative-ion spectra have been sim-
plified. In Figure 7b, the signals observed at m/z 1385
Diagram 1
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and 1414 correspond to [M 2 H]2 ions of the GM2
structure, whereas m/z 1547 and 1575 correspond to
[M 2 H]2 ions of the GM1. Signals at m/z 1837 and 1865
correspond to [M 2 H]2 ions of GD1a or 1b having
sphingosine (d18:1) and icosasphingosine (d20:1), re-
spectively, whereas [M1Na 2 2H]2 ions of GD1a or 1b
were determined at m/z 1859 and 1888, respectively.
Finally, the signals at m/z 2128 and 2156 correspond to
GT1b structure.
Conclusions
Inclusion of spermine as a co-matrix to DHB has been
shown here to improve substantially the scope of the
MALDI analysis for acidic glycans. Simple mass spectra
were successfully acquired in the negative-ion mode for
a variety of sialylated oligosaccharides and ganglio-
sides down to the femtomole levels. Addition of sperm-
ine to DHB appears to minimize sodium adduction,
thus reducing the needs for sample desalting prior to a
MALDI analysis. In the cases when spermine does not
totally eliminate adduct formation, the major ion pro-
duced during the MALDI process is easily accounted
for as an equivalent to the number of acidic groups
minus one sialic residue. Through the use of specific
neuraminidases, the nature of sialic linkages can also be
assessed.
Figure 7. Negative-ion spectra of a ganglioside mixture before (a) and after (b) treatment with
ammonium hydroxide.
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